Related by context. Frequent words. (Click for all words.) 65 R sorafenib tablets 64 Receives Orphan Drug Designation 64 Kuvan R 63 pancreatic neuroendocrine tumors 63 Initiates Phase II 62 sunitinib malate 62 secondary hyperparathyroidism 62 Nexavar ® 62 Meets Primary Endpoint 61 post herpetic neuralgia PHN 61 Irinotecan 61 IRESSA 61 liposomal formulation 61 personalized immunotherapy 61 pancreatic NET 61 forodesine 61 immuno inflammatory diseases 61 TELINTRA 61 Cetrorelix 60 Octreotide 60 relapsing multiple sclerosis 60 Vandetanib 60 Daclizumab 60 Lubiprostone 60 Drug Candidate 60 Ixempra 60 Mipomersen 60 refractory chronic lymphocytic 60 Syntonix 60 opioid induced constipation 60 Pirfenidone 59 Factor VIIa 59 Azilect ® 59 Lenalidomide 59 relapsed multiple myeloma 59 Microplasmin 59 Myelodysplastic Syndromes 59 Panzem R 59 prophylactic therapy 59 Torisel 59 efalizumab 59 castrate resistant prostate cancer 59 hereditary antithrombin deficiency 59 orphan medicinal product 59 myeloproliferative disorders 59 Allovectin 7 ® 59 immunologic diseases 59 multiple myeloma MM 59 VALSTAR 59 gastrointestinal stromal tumors GIST 59 TTR amyloidosis 59 Atopic Dermatitis 58 Tacrolimus 58 Mucositis 58 Tavocept 58 Idiopathic Pulmonary Fibrosis 58 Amrubicin 58 Myelofibrosis 58 Soliris TM eculizumab 58 oropharyngeal candidiasis 58 Diabetic Neuropathy 58 Golimumab 58 Dasatinib 58 multi kinase inhibitor 58 ankylosing spondylitis AS 58 solid organ transplantation 58 Amphotericin B 58 deforolimus 58 Overactive Bladder 58 Allergic Rhinitis 58 Chronic Heart Failure 58 FDA Accepts 58 Hepatocellular Carcinoma 58 Presents Positive 58 inflammatory autoimmune diseases 58 chronic hepatitis B. 58 Epratuzumab 58 Cethromycin 58 immunological diseases 58 Autoimmune Diseases 58 THALOMID 58 autoimmune indications 57 pancreatic insufficiency 57 Clinical Trial Results 57 candidemia 57 oral candidiasis 57 Entereg R 57 PsA 57 Benign Prostatic Hyperplasia 57 idiopathic pulmonary fibrosis IPF 57 recurrent glioblastoma 57 thrombotic disorders 57 Completes Enrollment 57 MPS VI 57 Autoimmune Disease 57 rufinamide 57 venous thromboembolic events 57 eslicarbazepine acetate 57 Drug Shows Promise 57 mycophenolate mofetil 57 colorectal lung